sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug

$363,671

Weidong Wang · National Institute On Aging · ZIA · FY2025 · AG

Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients

$362,250

Rong Xu · Case Western Reserve University · R01 · FY2021 · AA

Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients

$362,250

Rong Xu · Case Western Reserve University · R01 · FY2023 · AA

Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients

$362,250

Rong Xu · Case Western Reserve University · R01 · FY2022 · AA

Multiplexed Airborne Virus Collection and Detection at the Point-of-Care

$362,126

Z. Hugh Fan · University Of Florida · R01 · FY2025 · AI

Structures and Dynamics of Proton and Cation-Dependent Channels and Transporters

$361,858

Mei Hong · Massachusetts Institute Of Technology · R01 · FY2021 · GM

Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck

$361,844

Joshua Labaer · Arizona State University-Tempe Campus · R33 · FY2024 · CA

Defining The Immune Response to SARS-CoV-2 in Aging

$361,494

Joren C Madsen · Massachusetts General Hospital · U01 · FY2020 · AI

Immunologic Studies Associated with COVID-19

$361,442

Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Modeling Core

$361,395

Luis A. Nunes Amaral · Northwestern University At Chicago · U19 · FY2024 · AI

Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure

$360,917

Debra Mackenzie · University Of New Mexico Health Scis Ctr · UH3 · FY2025 · OD

A Predictive Modeling Framework to Dissect the Dynamic Immunometabolic Responses to Pathogenic infection and the Kinetic Reprogramming of Metabolism in Cancer Cell System

$360,899

Rajib Saha · University Of Nebraska Lincoln · R35 · FY2025 · GM

Human Airway Biomimetics for RSV and Other Respiratory Viruses

$360,700

Pedro A Piedra · Baylor College Of Medicine · U19 · FY2025 · AI

Investigating SARS-CoV-2 Vaccine Hesitancy in Houston

$360,606

Ezemenari M Obasi · University Of Houston · U54 · FY2021 · MD

Project 1 - A systems biology approach to identify early networks and signatures associated with mild and severe SARS-CoV-2 infections in vivo

$360,450

Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI

Understanding longitudinal relationships between COVID-19 pandemic outcomes and alcohol use and problems from 2019 to 2020 and 2021 for the U.S. population and vulnerable groups.

$360,450

Priscilla Martinez · Public Health Institute · R01 · FY2022 · AA

Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug

Unraveling the Viral Infection Pathway with Virus-locked Observation

Bioinformatics Framework for Wastewater-based Surveillance of SARS-CoV-2

Novel RNA Structures in Coronavirus Replication

Sympathetic-Vascular Dysfunction in Obesity-Related Hypertension

Multiplexed Airborne Virus Collection and Detection at the Point-of-Care

Multiplexed Airborne Virus Collection and Detection at the Point-of-Care

SARS-CoV S Protein Receptor-binding Domain-based Vaccines

SARS-CoV S Protein Receptor-binding Domain-based Vaccines

BSL3 Flow Sorter for Human Pathogens of Global Significance

Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients

Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients

Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients

Multiplexed Airborne Virus Collection and Detection at the Point-of-Care

Structures and Dynamics of Proton and Cation-Dependent Channels and Transporters

Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck

Defining The Immune Response to SARS-CoV-2 in Aging

Immunologic Studies Associated with COVID-19

Modeling Core

Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure

A Predictive Modeling Framework to Dissect the Dynamic Immunometabolic Responses to Pathogenic infection and the Kinetic Reprogramming of Metabolism in Cancer Cell System

Human Airway Biomimetics for RSV and Other Respiratory Viruses

Investigating SARS-CoV-2 Vaccine Hesitancy in Houston

Project 1 - A systems biology approach to identify early networks and signatures associated with mild and severe SARS-CoV-2 infections in vivo

Understanding longitudinal relationships between COVID-19 pandemic outcomes and alcohol use and problems from 2019 to 2020 and 2021 for the U.S. population and vulnerable groups.